Parul Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Parul Singh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ayden Case
Department of Medicine (A.G.C., J.W.O., F.T.W.C., A.B.A.K.A.-H., S.A.N., Z.H., G.B., X.Z., Z.M., T.X.Z.), University of Cambridge, United Kingdom
1 shared publication - Claudia Kemper
Complement and Inflammation Research Section, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA
1 shared publication - Eli A. Boritz
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
1 shared publication - Erin E. West
Complement and Inflammation Research Section, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA
1 shared publication - Gaelle Le Friec
UCB, Slough, Berkshire, UK
1 shared publication Henrik Hasle
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
1 shared publication
Latest Publications
- 10 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (121) , eaeb5857
Sp1 links CD46 to CD4 T cell metabolic fitness, survival, and retroviral control
CD46, a human-specific complement receptor, regulates gene programs essential for T helper 1 (T H 1) cell differentiation, yet how it exerts direct transcriptional control remains unclear. We show that the CD46 signaling domain cytoplasmic tail 1 (CYT-1) engages the transcription factor Sp1 in human CD4 T cells to dynamically modulate Sp1-DNA interactions. Beyond promoting T H 1 cell induction, CD46-Sp1–controlled programs support naive CD4 T cell survival by maintaining nutrient transporter expression and suppressing the intrinsic caspase 9–caspase 3 apoptotic pathway. The CD46-Sp1 axis also restrains HIV transcription in infected CD4 T cells in vitro. Disruption of CYT-1–Sp1–regulated programs identifies T cells from individuals with HIV who exhibit incomplete viral suppression during antiretroviral therapy. Together, these findings define a human-specific transcriptional mechanism linking complement signaling to metabolic adaptation, apoptosis regulation, and antiviral defense, highlighting an unexpected role for CD46 in coordinating T cell homeostasis and host protection.
- 10 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (121) , eaeb5857
Sp1 links CD46 to CD4 T cell metabolic fitness, survival, and retroviral control
CD46, a human-specific complement receptor, regulates gene programs essential for T helper 1 (T H 1) cell differentiation, yet how it exerts direct transcriptional control remains unclear. We show that the CD46 signaling domain cytoplasmic tail 1 (CYT-1) engages the transcription factor Sp1 in human CD4 T cells to dynamically modulate Sp1-DNA interactions. Beyond promoting T H 1 cell induction, CD46-Sp1–controlled programs support naive CD4 T cell survival by maintaining nutrient transporter expression and suppressing the intrinsic caspase 9–caspase 3 apoptotic pathway. The CD46-Sp1 axis also restrains HIV transcription in infected CD4 T cells in vitro. Disruption of CYT-1–Sp1–regulated programs identifies T cells from individuals with HIV who exhibit incomplete viral suppression during antiretroviral therapy. Together, these findings define a human-specific transcriptional mechanism linking complement signaling to metabolic adaptation, apoptosis regulation, and antiviral defense, highlighting an unexpected role for CD46 in coordinating T cell homeostasis and host protection.